Related references
Note: Only part of the references are listed.Patient and provider factors associated with the noninitiation of tamoxifen for young women at high-risk for the development of breast cancer
Pridvi Kandagatla et al.
BREAST JOURNAL (2020)
The Tyrer-Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS
Monica G. Valero et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing
Brittany L. Murphy et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Management of women at increased risk for breast cancer secondary to high-risk proliferative lesions and family history of the disease
Cindy Cen et al.
BREAST JOURNAL (2020)
Chemoprevention Uptake for Breast Cancer Risk Reduction Varies by Risk Factor
Meghan R. Flanagan et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
The REDCap consortium: Building an international community of software platform partners
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2019)
Shared decision making in oncology: A model based on patients', health care professionals', and researchers' views
Hanna Bomhof-Roordink et al.
PSYCHO-ONCOLOGY (2019)
Risk Stratification for Screening Mammography: Benefits and Harms
Cindy S. Lee et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2019)
Breast Atypia as a Biomarker of Risk
Amy C. Degnim
CURRENT BREAST CANCER REPORTS (2019)
Breast cancer risk prediction in women aged 35-50years: impact of including sex hormone concentrations in the Gail model
Tess V. Clendenen et al.
BREAST CANCER RESEARCH (2019)
Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients
Antuono Latronico et al.
BREAST (2018)
Breast Cancer Screening and Diagnosis, Version 3.2018
Therese B. Bevers et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle Biopsy
Tehillah S. Menes et al.
JAMA ONCOLOGY (2017)
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
Fergus J. Couch et al.
JAMA ONCOLOGY (2017)
Multi-institutional Evaluation of Women at High Risk of Developing Breast Cancer
David J. Hermel et al.
CLINICAL BREAST CANCER (2017)
Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ
Meghna S. Trivedi et al.
CANCER PREVENTION RESEARCH (2017)
Family history and risk of breast cancer: an analysis accounting for family structure
Hannah R. Brewer et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer
Jada G. Hamilton et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis
S. G. Smith et al.
ANNALS OF ONCOLOGY (2016)
Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review
Kandice K. Ludwig et al.
AMERICAN JOURNAL OF SURGERY (2016)
Chemoprevention for Breast Cancer
Sandhya Pruthi et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Implementing and Evaluating Shared Decision Making in Oncology Practice
Heather L. Kane et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial
Jack Cuzick et al.
LANCET (2014)
Does the use of shared decision-making consultation behaviors increase treatment decision-making satisfaction among Chinese women facing decision for breast cancer surgery?
Wendy W. T. Lam et al.
PATIENT EDUCATION AND COUNSELING (2014)
Shared Decision Making in Oncology Practice: What Do Oncologists Need to Know?
Mary C. Politi et al.
ONCOLOGIST (2012)
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
Paul E. Goss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Factors Affecting the Decision of Breast Cancer Patients to Undergo Contralateral Prophylactic Mastectomy
Min Yi et al.
CANCER PREVENTION RESEARCH (2010)
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction
Kala Visvanathan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Timing of menarche, childbearing and hysterectomy risk
Rachel Cooper et al.
MATURITAS (2008)
Does worry about breast cancer predict screening behaviors? A meta-analysis of the prospective evidence
Jennifer L. Hay et al.
PREVENTIVE MEDICINE (2006)
A qualitative study looking at the psychosocial implications of bilateral prophylactic mastectomy
MB Hatcher et al.
BREAST (2003)
The psychological outcome of hysterectomy
G Khastgir et al.
GYNECOLOGICAL ENDOCRINOLOGY (2000)
Share Paper
